| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 3.79e-06 | 5 | 146 | 3 | GO:0050649 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.21e-05 | 20 | 146 | 4 | GO:0061665 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 1.50e-05 | 43 | 146 | 5 | GO:0030280 | |
| GeneOntologyMolecularFunction | estrogen 2-hydroxylase activity | 2.09e-05 | 8 | 146 | 3 | GO:0101021 | |
| GeneOntologyMolecularFunction | estrogen 16-alpha-hydroxylase activity | 6.05e-05 | 11 | 146 | 3 | GO:0101020 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | RGPD4 DOCK4 RANBP2 RGPD8 CYTH2 OBSCN RAP1GAP2 ANKRD27 SBF1 RGPD3 EIF2B5 BCAR3 RGPD5 | 9.19e-05 | 507 | 146 | 13 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | RGPD4 DOCK4 RANBP2 RGPD8 CYTH2 OBSCN RAP1GAP2 ANKRD27 SBF1 RGPD3 EIF2B5 BCAR3 RGPD5 | 9.19e-05 | 507 | 146 | 13 | GO:0030695 |
| GeneOntologyMolecularFunction | calcium ion binding | PCDHB10 ADAMTS13 F2 ITIH4 EHD3 MMRN1 SCUBE1 CELSR1 SCUBE2 AOC3 SCUBE3 MACF1 PLCB2 CDH5 PCDH7 CDH17 | 1.21e-04 | 749 | 146 | 16 | GO:0005509 |
| GeneOntologyMolecularFunction | retinoic acid 4-hydroxylase activity | 1.31e-04 | 14 | 146 | 3 | GO:0008401 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.35e-04 | 36 | 146 | 4 | GO:0019789 | |
| GeneOntologyMolecularFunction | testosterone 16-alpha-hydroxylase activity | 3.16e-04 | 4 | 146 | 2 | GO:0008390 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 4.86e-04 | 50 | 146 | 4 | GO:0003755 | |
| GeneOntologyMolecularFunction | vitamin D 23-hydroxylase activity | 5.23e-04 | 5 | 146 | 2 | GO:0062179 | |
| GeneOntologyMolecularFunction | 1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activity | 5.23e-04 | 5 | 146 | 2 | GO:0062181 | |
| GeneOntologyMolecularFunction | small GTPase binding | 6.04e-04 | 321 | 146 | 9 | GO:0031267 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 6.08e-04 | 53 | 146 | 4 | GO:0016859 | |
| GeneOntologyMolecularFunction | vitamin D3 25-hydroxylase activity | 7.81e-04 | 6 | 146 | 2 | GO:0030343 | |
| GeneOntologyMolecularFunction | vitamin D 24-hydroxylase activity | 7.81e-04 | 6 | 146 | 2 | GO:0070576 | |
| GeneOntologyMolecularFunction | structural molecule activity | KRT78 KRT16 KRT81 KRT83 KRT85 KRT86 OBSCN NUP98 LAMB2 OGN BFSP1 MMRN1 NEFM DES NEFL MACF1 | 8.26e-04 | 891 | 146 | 16 | GO:0005198 |
| GeneOntologyMolecularFunction | GTPase activator activity | 1.05e-03 | 279 | 146 | 8 | GO:0005096 | |
| GeneOntologyMolecularFunction | vitamin D 25-hydroxylase activity | 1.09e-03 | 7 | 146 | 2 | GO:0070643 | |
| GeneOntologyMolecularFunction | GTPase binding | 1.35e-03 | 360 | 146 | 9 | GO:0051020 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor | 1.44e-03 | 8 | 146 | 2 | GO:0033695 | |
| GeneOntologyMolecularFunction | caffeine oxidase activity | 1.44e-03 | 8 | 146 | 2 | GO:0034875 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 1.58e-03 | 231 | 146 | 7 | GO:0005085 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 1.94e-03 | 34 | 146 | 3 | GO:0008395 | |
| GeneOntologyMolecularFunction | aromatase activity | 2.11e-03 | 35 | 146 | 3 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxygen binding | 2.48e-03 | 37 | 146 | 3 | GO:0019825 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 2.69e-03 | 130 | 146 | 5 | GO:0005200 | |
| GeneOntologyMolecularFunction | inositol phosphate kinase activity | 2.80e-03 | 11 | 146 | 2 | GO:0180030 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | KRT78 KRT16 KRT81 KRT83 KRT85 KRT86 BFSP1 NEFM DES NEFL MACF1 | 7.75e-11 | 99 | 141 | 11 | GO:0045104 |
| GeneOntologyBiologicalProcess | intermediate filament-based process | KRT78 KRT16 KRT81 KRT83 KRT85 KRT86 BFSP1 NEFM DES NEFL MACF1 | 8.66e-11 | 100 | 141 | 11 | GO:0045103 |
| GeneOntologyBiologicalProcess | intermediate filament organization | 9.17e-11 | 75 | 141 | 10 | GO:0045109 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 1.98e-07 | 20 | 141 | 5 | GO:0006607 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 2.57e-07 | 9 | 141 | 4 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 4.26e-07 | 10 | 141 | 4 | GO:1903301 | |
| GeneOntologyBiologicalProcess | regulation of cell morphogenesis | DHX36 SPAG9 F2 ANKRD27 PTK2 CRK ITPKA TAOK2 IL1RAPL1 MACF1 HCK PLXNB3 | 1.16e-06 | 302 | 141 | 12 | GO:0022604 |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.43e-06 | 13 | 141 | 4 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 1.99e-06 | 14 | 141 | 4 | GO:1903299 | |
| GeneOntologyBiologicalProcess | lipid hydroxylation | 2.55e-05 | 9 | 141 | 3 | GO:0002933 | |
| GeneOntologyBiologicalProcess | keratinization | 2.94e-05 | 87 | 141 | 6 | GO:0031424 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 3.36e-05 | 54 | 141 | 5 | GO:0018208 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 3.83e-05 | 134 | 141 | 7 | GO:0010906 | |
| GeneOntologyBiologicalProcess | regulation of anatomical structure morphogenesis | DHX36 SPAG9 YJEFN3 F2 ANKRD27 RYK PTK2 CRK ITPKA TAOK2 NEFM IL1RAPL1 NEFL CELSR1 BTBD7 DDHD1 MACF1 CDH5 HCK PLXNB3 | 5.28e-05 | 1090 | 141 | 20 | GO:0022603 |
| GeneOntologyBiologicalProcess | regulation of neurogenesis | DHX36 HAPLN2 F2 ANKRD27 RYK PTK2 ITPKA IL1RAPL1 NEFL SIRT2 MACF1 PLXNB3 TP53 | 5.43e-05 | 515 | 141 | 13 | GO:0050767 |
| GeneOntologyBiologicalProcess | oxidative demethylation | 6.58e-05 | 12 | 141 | 3 | GO:0070989 | |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | DHX36 CYTH2 RAP1GAP2 ANKRD27 RYK PTK2 CRK ITPKA NEFM IL1RAPL1 NEFL TENM3 MACF1 PLXNB3 | 8.02e-05 | 612 | 141 | 14 | GO:0010975 |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 1.26e-04 | 71 | 141 | 5 | GO:0006111 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.29e-04 | 38 | 141 | 4 | GO:0000413 | |
| GeneOntologyBiologicalProcess | neurofilament bundle assembly | 1.39e-04 | 3 | 141 | 2 | GO:0033693 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | DHX36 UNC5B LAMB2 SPAG9 F2 ANKRD27 RYK PTK2 CRK ITPKA TAOK2 NEFM IL1RAPL1 NEFL HRH2 MACF1 CDH5 HCK PLXNB3 CDH17 | 1.82e-04 | 1194 | 141 | 20 | GO:0000902 |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 2.11e-04 | 124 | 141 | 6 | GO:0007229 | |
| GeneOntologyBiologicalProcess | intermediate filament polymerization or depolymerization | 2.76e-04 | 4 | 141 | 2 | GO:0045105 | |
| GeneOntologyBiologicalProcess | glucose metabolic process | 2.80e-04 | 244 | 141 | 8 | GO:0006006 | |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 2.96e-04 | 132 | 141 | 6 | GO:0043255 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 3.06e-04 | 187 | 141 | 7 | GO:0007156 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 3.09e-04 | 313 | 141 | 9 | GO:0098742 | |
| GeneOntologyBiologicalProcess | positive regulation of execution phase of apoptosis | 3.27e-04 | 20 | 141 | 3 | GO:1900119 | |
| GeneOntologyBiologicalProcess | cell junction organization | DHX36 OGT DRP2 MYO1C PCDHB10 LAMB2 RYK PTK2 CRK ITPKA TAOK2 IL1RAPL1 NEFL TENM3 MACF1 CDH5 CDH17 | 3.60e-04 | 974 | 141 | 17 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | DHX36 HAPLN2 F2 ANKRD27 RYK PTK2 ITPKA IL1RAPL1 NEFL SIRT2 MACF1 PLXNB3 TP53 | 3.65e-04 | 625 | 141 | 13 | GO:0051960 |
| GeneOntologyBiologicalProcess | protein import into nucleus | 3.94e-04 | 195 | 141 | 7 | GO:0006606 | |
| GeneOntologyBiologicalProcess | alkaloid catabolic process | 4.58e-04 | 5 | 141 | 2 | GO:0009822 | |
| GeneOntologyBiologicalProcess | import into nucleus | 4.73e-04 | 201 | 141 | 7 | GO:0051170 | |
| GeneOntologyBiologicalProcess | demethylation | 5.70e-04 | 24 | 141 | 3 | GO:0070988 | |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 5.86e-04 | 150 | 141 | 6 | GO:0050773 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 3.80e-09 | 10 | 146 | 5 | GO:0044614 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.24e-07 | 18 | 146 | 5 | GO:0044615 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 1.56e-07 | 8 | 146 | 4 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 2.21e-07 | 20 | 146 | 5 | GO:0042405 | |
| GeneOntologyCellularComponent | intermediate filament | KRT78 KRT16 KRT81 KRT83 KRT85 KRT86 BFSP1 NEFM DES NEFL MACF1 | 5.89e-07 | 227 | 146 | 11 | GO:0005882 |
| GeneOntologyCellularComponent | annulate lamellae | 2.16e-06 | 14 | 146 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | KRT78 KRT16 KRT81 KRT83 KRT85 KRT86 BFSP1 NEFM DES NEFL MACF1 | 2.48e-06 | 263 | 146 | 11 | GO:0045111 |
| GeneOntologyCellularComponent | inclusion body | 3.23e-06 | 90 | 146 | 7 | GO:0016234 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 1.25e-05 | 21 | 146 | 4 | GO:0106068 | |
| GeneOntologyCellularComponent | keratin filament | 6.14e-05 | 97 | 146 | 6 | GO:0045095 | |
| GeneOntologyCellularComponent | nuclear pore | 7.69e-05 | 101 | 146 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | presynaptic intermediate filament cytoskeleton | 1.45e-04 | 3 | 146 | 2 | GO:0099182 | |
| GeneOntologyCellularComponent | polymeric cytoskeletal fiber | KRT78 KRT16 MYO1C KRT81 KRT83 KRT85 KRT86 DNAH2 BFSP1 NEFM DES NEFL SIRT2 EML5 MACF1 HCK CSTPP1 | 1.84e-04 | 899 | 146 | 17 | GO:0099513 |
| GeneOntologyCellularComponent | postsynaptic intermediate filament cytoskeleton | 2.88e-04 | 4 | 146 | 2 | GO:0099160 | |
| GeneOntologyCellularComponent | supramolecular fiber | KRT78 KRT16 MYO1C KRT81 KRT83 KRT85 KRT86 OBSCN DNAH2 BFSP1 NEFM DES NEFL SIRT2 EML5 MACF1 CTPS1 HCK CSTPP1 | 5.70e-04 | 1179 | 146 | 19 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | KRT78 KRT16 MYO1C KRT81 KRT83 KRT85 KRT86 OBSCN DNAH2 BFSP1 NEFM DES NEFL SIRT2 EML5 MACF1 CTPS1 HCK CSTPP1 | 6.19e-04 | 1187 | 146 | 19 | GO:0099081 |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 7.71e-04 | 26 | 146 | 3 | GO:0099571 | |
| GeneOntologyCellularComponent | neuromuscular junction | 1.14e-03 | 112 | 146 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | RGPD4 DCAF1 TEAD2 RANBP2 OGT GTF2A1L RGPD8 MYO1C RBBP5 SF3A1 NUP98 E2F6 RAD50 DHX15 SIRT2 SUV39H1 RGPD3 IK TP53 RGPD5 | 1.46e-03 | 1377 | 146 | 20 | GO:0140513 |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 2.18e-03 | 78 | 146 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | RGPD4 RANBP2 RGPD8 GDPD3 APBA1 RAP1GAP2 SPAG9 PTK2 EHD3 RAD50 RASIP1 SIRT2 SBF1 RGPD3 RASD1 | 2.29e-03 | 934 | 146 | 15 | GO:0048471 |
| HumanPheno | Perifollicular hyperkeratosis | 2.93e-06 | 4 | 47 | 3 | HP:0007468 | |
| HumanPheno | Brittle hair | 8.22e-06 | 54 | 47 | 6 | HP:0002299 | |
| HumanPheno | Abnormal perifollicular morphology | 1.44e-05 | 6 | 47 | 3 | HP:0031285 | |
| HumanPheno | Nail dystrophy | 7.36e-05 | 156 | 47 | 8 | HP:0008404 | |
| HumanPheno | Reduced peroxisomal glutaryl-CoA oxidase activity | 8.33e-05 | 2 | 47 | 2 | HP:0034688 | |
| MousePheno | aneuploidy | 1.19e-06 | 61 | 126 | 7 | MP:0004024 | |
| MousePheno | decreased tumor latency | 6.53e-06 | 30 | 126 | 5 | MP:0010308 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 1.05e-05 | 16 | 126 | 4 | MP:0003701 | |
| MousePheno | abnormal chromosome number | 1.22e-05 | 86 | 126 | 7 | MP:0004023 | |
| MousePheno | abnormal tumor latency | 1.24e-05 | 34 | 126 | 5 | MP:0010307 | |
| MousePheno | increased hepatocellular carcinoma incidence | 3.89e-05 | 70 | 126 | 6 | MP:0003331 | |
| MousePheno | increased respiratory system tumor incidence | 5.05e-05 | 107 | 126 | 7 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 5.05e-05 | 107 | 126 | 7 | MP:0008014 | |
| MousePheno | increased hepatobiliary system tumor incidence | 6.39e-05 | 111 | 126 | 7 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 6.39e-05 | 111 | 126 | 7 | MP:0008019 | |
| MousePheno | increased lung carcinoma incidence | 7.19e-05 | 78 | 126 | 6 | MP:0008714 | |
| MousePheno | abnormal morula morphology | 8.07e-05 | 26 | 126 | 4 | MP:0012058 | |
| MousePheno | abnormal chromosome morphology | 1.42e-04 | 126 | 126 | 7 | MP:0003702 | |
| MousePheno | failure of blastocyst formation | 1.64e-04 | 31 | 126 | 4 | MP:0012129 | |
| Domain | Filament | 1.46e-10 | 71 | 142 | 10 | SM01391 | |
| Domain | IF | 1.68e-10 | 72 | 142 | 10 | PS00226 | |
| Domain | Filament | 1.94e-10 | 73 | 142 | 10 | PF00038 | |
| Domain | IF | 2.92e-10 | 76 | 142 | 10 | IPR001664 | |
| Domain | Intermediate_filament_CS | 1.10e-09 | 63 | 142 | 9 | IPR018039 | |
| Domain | Ran_BP1 | 1.80e-08 | 12 | 142 | 5 | PF00638 | |
| Domain | RANBD1 | 1.80e-08 | 12 | 142 | 5 | PS50196 | |
| Domain | RanBD | 2.90e-08 | 13 | 142 | 5 | SM00160 | |
| Domain | Ran_bind_dom | 2.90e-08 | 13 | 142 | 5 | IPR000156 | |
| Domain | TPR_REGION | RGPD4 RANBP2 OGT RGPD8 DNAH2 TTC27 RGPD3 STIP1 LONRF3 DNAJC3 RGPD5 | 5.38e-08 | 165 | 142 | 11 | PS50293 |
| Domain | TPR | RGPD4 RANBP2 OGT RGPD8 DNAH2 TTC27 RGPD3 STIP1 LONRF3 DNAJC3 RGPD5 | 5.38e-08 | 165 | 142 | 11 | PS50005 |
| Domain | TPR-contain_dom | RGPD4 RANBP2 OGT RGPD8 TTC27 RGPD3 STIP1 LONRF3 DNAJC3 RGPD5 | 2.22e-07 | 150 | 142 | 10 | IPR013026 |
| Domain | TPR | 6.22e-07 | 129 | 142 | 9 | SM00028 | |
| Domain | TPR_repeat | 8.06e-07 | 133 | 142 | 9 | IPR019734 | |
| Domain | Keratin_2_head | 8.96e-07 | 24 | 142 | 5 | IPR032444 | |
| Domain | Keratin_2_head | 8.96e-07 | 24 | 142 | 5 | PF16208 | |
| Domain | Grip | 1.01e-06 | 11 | 142 | 4 | SM00755 | |
| Domain | GRIP | 1.01e-06 | 11 | 142 | 4 | PF01465 | |
| Domain | Keratin_II | 1.37e-06 | 26 | 142 | 5 | IPR003054 | |
| Domain | GRIP_dom | 1.51e-06 | 12 | 142 | 4 | IPR000237 | |
| Domain | GRIP | 1.51e-06 | 12 | 142 | 4 | PS50913 | |
| Domain | Cyt_P450_E_grp-II | 4.26e-06 | 5 | 142 | 3 | IPR002402 | |
| Domain | Cyt_P450_E_CYP3A | 8.46e-06 | 6 | 142 | 3 | IPR008072 | |
| Domain | TPR-like_helical_dom | RGPD4 RANBP2 OGT RGPD8 TTC27 RGPD3 STIP1 LONRF3 DNAJC3 RGPD5 | 1.19e-05 | 233 | 142 | 10 | IPR011990 |
| Domain | Rab_bind | 1.47e-05 | 7 | 142 | 3 | PF16704 | |
| Domain | Filament_head | 1.47e-05 | 7 | 142 | 3 | PF04732 | |
| Domain | GCC2_Rab_bind | 1.47e-05 | 7 | 142 | 3 | IPR032023 | |
| Domain | Intermed_filament_DNA-bd | 1.47e-05 | 7 | 142 | 3 | IPR006821 | |
| Domain | PH_dom-like | RGPD4 RANBP2 RGPD8 CYTH2 OBSCN APBA1 TEC NIBAN3 PTK2 SBF1 RGPD3 PLCB2 RGPD5 | 2.28e-05 | 426 | 142 | 13 | IPR011993 |
| Domain | - | 2.97e-05 | 207 | 142 | 9 | 1.25.40.10 | |
| Domain | - | 4.97e-05 | 10 | 142 | 3 | 1.10.220.60 | |
| Domain | TPR_1 | 6.40e-05 | 90 | 142 | 6 | IPR001440 | |
| Domain | TPR_1 | 6.40e-05 | 90 | 142 | 6 | PF00515 | |
| Domain | Ephrin_rec_like | 6.79e-05 | 11 | 142 | 3 | PF07699 | |
| Domain | EGF_dom | 9.00e-05 | 12 | 142 | 3 | IPR024731 | |
| Domain | EGF_3 | 9.00e-05 | 12 | 142 | 3 | PF12947 | |
| Domain | CA | 2.48e-04 | 115 | 142 | 6 | SM00112 | |
| Domain | Cadherin | 2.85e-04 | 118 | 142 | 6 | IPR002126 | |
| Domain | WD40_repeat_dom | 4.54e-04 | 297 | 142 | 9 | IPR017986 | |
| Domain | CUB | 7.02e-04 | 53 | 142 | 4 | PS01180 | |
| Domain | - | 8.26e-04 | 391 | 142 | 10 | 2.30.29.30 | |
| Domain | - | 8.44e-04 | 6 | 142 | 2 | 2.40.50.90 | |
| Domain | Staphylococal_nuclease_OB-fold | 8.44e-04 | 6 | 142 | 2 | IPR016071 | |
| Domain | PROTEIN_KINASE_TYR | 8.71e-04 | 97 | 142 | 5 | PS00109 | |
| Domain | Tyr_kinase_AS | 8.71e-04 | 97 | 142 | 5 | IPR008266 | |
| Domain | Ephrin_rec_like | 8.75e-04 | 25 | 142 | 3 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 8.75e-04 | 25 | 142 | 3 | IPR011641 | |
| Domain | CUB_dom | 9.26e-04 | 57 | 142 | 4 | IPR000859 | |
| Domain | cEGF | 9.84e-04 | 26 | 142 | 3 | PF12662 | |
| Domain | cEGF | 9.84e-04 | 26 | 142 | 3 | IPR026823 | |
| Domain | - | 1.03e-03 | 333 | 142 | 9 | 2.130.10.10 | |
| Domain | WD40/YVTN_repeat-like_dom | 1.07e-03 | 335 | 142 | 9 | IPR015943 | |
| Domain | TPR_11 | 1.18e-03 | 7 | 142 | 2 | PF13414 | |
| Domain | Growth_fac_rcpt_ | 1.24e-03 | 156 | 142 | 6 | IPR009030 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.30e-03 | 106 | 142 | 5 | IPR000152 | |
| Domain | Cadherin_CS | 1.47e-03 | 109 | 142 | 5 | IPR020894 | |
| Domain | DUF1669 | 1.56e-03 | 8 | 142 | 2 | PF07894 | |
| Domain | DUF1669 | 1.56e-03 | 8 | 142 | 2 | IPR012461 | |
| Domain | CADHERIN_1 | 1.72e-03 | 113 | 142 | 5 | PS00232 | |
| Domain | Cadherin | 1.72e-03 | 113 | 142 | 5 | PF00028 | |
| Domain | CADHERIN_2 | 1.79e-03 | 114 | 142 | 5 | PS50268 | |
| Domain | - | 1.79e-03 | 114 | 142 | 5 | 2.60.40.60 | |
| Domain | Cadherin-like | 1.93e-03 | 116 | 142 | 5 | IPR015919 | |
| Domain | EGF | 2.16e-03 | 235 | 142 | 7 | SM00181 | |
| Domain | EGF_CA | 2.41e-03 | 122 | 142 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.58e-03 | 124 | 142 | 5 | IPR001881 | |
| Domain | EGF-like_dom | 2.98e-03 | 249 | 142 | 7 | IPR000742 | |
| Domain | EGF_1 | 3.40e-03 | 255 | 142 | 7 | PS00022 | |
| Domain | EGF-like_CS | 3.86e-03 | 261 | 142 | 7 | IPR013032 | |
| Domain | EGF_2 | 4.19e-03 | 265 | 142 | 7 | PS01186 | |
| Domain | Tyr_kinase_cat_dom | 4.56e-03 | 88 | 142 | 4 | IPR020635 | |
| Domain | TyrKc | 4.56e-03 | 88 | 142 | 4 | SM00219 | |
| Domain | TUDOR | 4.92e-03 | 14 | 142 | 2 | PF00567 | |
| Domain | WD_REPEATS_1 | 5.43e-03 | 278 | 142 | 7 | PS00678 | |
| Domain | WD_REPEATS_2 | 5.53e-03 | 279 | 142 | 7 | PS50082 | |
| Domain | WD_REPEATS_REGION | 5.53e-03 | 279 | 142 | 7 | PS50294 | |
| Domain | CUB | 6.14e-03 | 49 | 142 | 3 | PF00431 | |
| Domain | SH3 | 6.21e-03 | 216 | 142 | 6 | PS50002 | |
| Domain | Methyltransf_11 | 6.42e-03 | 16 | 142 | 2 | IPR013216 | |
| Domain | Methyltransf_11 | 6.42e-03 | 16 | 142 | 2 | PF08241 | |
| Domain | CUB | 6.50e-03 | 50 | 142 | 3 | SM00042 | |
| Domain | TPR_2 | 6.50e-03 | 50 | 142 | 3 | PF07719 | |
| Domain | TPR_2 | 6.50e-03 | 50 | 142 | 3 | IPR013105 | |
| Domain | SH3_domain | 6.78e-03 | 220 | 142 | 6 | IPR001452 | |
| Domain | ASX_HYDROXYL | 7.15e-03 | 100 | 142 | 4 | PS00010 | |
| Domain | DUF1605 | 7.24e-03 | 17 | 142 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 7.24e-03 | 17 | 142 | 2 | PF07717 | |
| Domain | - | 7.24e-03 | 52 | 142 | 3 | 2.60.120.290 | |
| Domain | SH2 | 7.40e-03 | 101 | 142 | 4 | PF00017 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 1.14e-05 | 18 | 114 | 4 | MM1549 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 1.66e-05 | 40 | 114 | 5 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 1.88e-05 | 41 | 114 | 5 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 2.12e-05 | 42 | 114 | 5 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 2.39e-05 | 43 | 114 | 5 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 3.70e-05 | 47 | 114 | 5 | MM14939 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 4.55e-05 | 49 | 114 | 5 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 5.02e-05 | 50 | 114 | 5 | MM14610 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 5.21e-05 | 82 | 114 | 6 | MM15394 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 5.53e-05 | 51 | 114 | 5 | MM15151 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 7.26e-05 | 87 | 114 | 6 | MM15351 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 7.98e-05 | 55 | 114 | 5 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.03e-04 | 58 | 114 | 5 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 1.03e-04 | 58 | 114 | 5 | MM14736 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.78e-04 | 65 | 114 | 5 | MM15147 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 2.33e-04 | 202 | 114 | 8 | MM15362 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 3.07e-04 | 73 | 114 | 5 | MM14948 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 5.88e-04 | 84 | 114 | 5 | MM14929 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 6.22e-04 | 129 | 114 | 6 | M27649 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 6.55e-04 | 86 | 114 | 5 | MM15413 | |
| Pubmed | RGPD4 KCTD12 RANBP2 OGT RGPD8 NPEPPS CYTH2 MCC WDR81 DIDO1 PTK2 ITIH4 EPM2AIP1 EHD3 RAD50 TAOK2 NEFM NEFL SBF1 RGPD3 MACF1 CEP131 STIP1 | 3.02e-11 | 963 | 150 | 23 | 28671696 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | DOCK4 KCTD12 DHX36 RANBP2 KRT78 OGT MYO1C NPEPPS KRT85 SF3A1 NUP98 BAK1 MCC TTC27 SPAG9 PTK2 RAD50 METTL13 SIRT2 MTHFD1 EIF2B5 STIP1 LNPK BCAR3 CTPS1 DEDD | 5.10e-11 | 1284 | 150 | 26 | 17353931 |
| Pubmed | RGPD4 RANBP2 OGT RGPD8 TTC27 E2F6 CRK RAD50 NEFM RGPD3 TMF1 CEP131 ZKSCAN4 PCCA CSTPP1 | 4.57e-10 | 418 | 150 | 15 | 34709266 | |
| Pubmed | DHX36 RANBP2 AARS1 MYO1C NPEPPS SF3A1 NUP98 DIDO1 SPAG9 TBL3 RAD50 DHX15 NEFM NEFL SBF1 MACF1 IK TP53 | 5.33e-10 | 653 | 150 | 18 | 22586326 | |
| Pubmed | Characterization of a 300 kbp region of human DNA containing the type II hair keratin gene domain. | 1.08e-09 | 12 | 150 | 5 | 10692104 | |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 1.75e-09 | 13 | 150 | 5 | 31427429 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | KCTD12 DHX36 RANBP2 AARS1 ATP8B4 MYO1C RBBP5 NPEPPS SF3A1 NUP98 PFKL F2 TBL3 RAD50 DHX15 METTL13 MTHFD1 EIF2B5 STIP1 TDRD6 IK CTPS1 TP53 SOAT1 CKMT1A | 2.38e-09 | 1425 | 150 | 25 | 30948266 |
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 9037092 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 21205196 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 24403063 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 23536549 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 12191015 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 22821000 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.15e-08 | 7 | 150 | 4 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.15e-08 | 7 | 150 | 4 | 11353387 | |
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 30944974 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.15e-08 | 7 | 150 | 4 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.15e-08 | 7 | 150 | 4 | 17372272 | |
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 38657106 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 18949001 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 25187515 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 8603673 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 26632511 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 23818861 | ||
| Pubmed | 1.15e-08 | 7 | 150 | 4 | 20682751 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | KCTD12 NPEPPS PFKL YJEFN3 OGN PTK2 EHD3 DHX15 NEFM NEFL SIRT2 MTHFD1 TDRD6 TSKS HCK CKMT1A | 1.33e-08 | 621 | 150 | 16 | 22794259 |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 2.30e-08 | 8 | 150 | 4 | 21670213 | |
| Pubmed | 2.30e-08 | 8 | 150 | 4 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 2.30e-08 | 8 | 150 | 4 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 2.30e-08 | 8 | 150 | 4 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 2.30e-08 | 8 | 150 | 4 | 28745977 | |
| Pubmed | 4.12e-08 | 9 | 150 | 4 | 28100513 | ||
| Pubmed | 4.12e-08 | 9 | 150 | 4 | 17887960 | ||
| Pubmed | 4.12e-08 | 9 | 150 | 4 | 9733766 | ||
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 4.12e-08 | 9 | 150 | 4 | 18394993 | |
| Pubmed | 4.12e-08 | 9 | 150 | 4 | 11553612 | ||
| Pubmed | 4.12e-08 | 9 | 150 | 4 | 10601307 | ||
| Pubmed | 4.12e-08 | 9 | 150 | 4 | 28877029 | ||
| Pubmed | KCTD12 DHX36 KRT78 OGT KRT16 MYO1C NPEPPS CYTH2 HAPLN2 PFKL YJEFN3 ITPKA EHD3 DHX15 NEFM NEFL SIRT2 SBF1 MTHFD1 MACF1 STIP1 HCK CKMT1A | 5.55e-08 | 1431 | 150 | 23 | 37142655 | |
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 6.84e-08 | 10 | 150 | 4 | 16332688 | |
| Pubmed | 6.84e-08 | 10 | 150 | 4 | 27160050 | ||
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 6.84e-08 | 10 | 150 | 4 | 8857542 | |
| Pubmed | 6.84e-08 | 10 | 150 | 4 | 21859863 | ||
| Pubmed | Novel KRT83 and KRT86 mutations associated with monilethrix. | 7.86e-08 | 3 | 150 | 3 | 25557232 | |
| Pubmed | Structure and site of expression of a murine type II hair keratin. | 7.86e-08 | 3 | 150 | 3 | 1372089 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 1712823 | ||
| Pubmed | Contribution of three CYP3A isoforms to metabolism of R- and S-warfarin. | 7.86e-08 | 3 | 150 | 3 | 20615193 | |
| Pubmed | Sequences and differential expression of three novel human type-II hair keratins. | 7.86e-08 | 3 | 150 | 3 | 9084137 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 32146629 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 17582393 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 19801957 | ||
| Pubmed | Identification of a novel family of cell-surface proteins expressed in human vascular endothelium. | 7.86e-08 | 3 | 150 | 3 | 12270931 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 20621111 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 8344946 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 20118548 | ||
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 31991528 | ||
| Pubmed | Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes. | 7.86e-08 | 3 | 150 | 3 | 23143891 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 33866277 | ||
| Pubmed | Comparison of steroid hormone hydroxylation mediated by cytochrome P450 3A subfamilies. | 7.86e-08 | 3 | 150 | 3 | 32001245 | |
| Pubmed | 7.86e-08 | 3 | 150 | 3 | 34688813 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RANBP2 KRT78 KRT16 NPEPPS SF3A1 KRT86 NUP98 LAMB2 PFKL TBL3 RAD50 DHX15 NEFL MTHFD1 MACF1 CEP131 STIP1 IK TP53 | 1.01e-07 | 1024 | 150 | 19 | 24711643 |
| Pubmed | 1.07e-07 | 11 | 150 | 4 | 17069463 | ||
| Pubmed | 1.07e-07 | 11 | 150 | 4 | 34110283 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.07e-07 | 11 | 150 | 4 | 35771867 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | KCTD12 RANBP2 AARS1 SF3A1 NUP98 DIDO1 SPAG9 PFKL NEDD1 RAD50 SIRT2 MTHFD1 MACF1 STIP1 CTPS1 PCCA TP53 CSTPP1 | 1.29e-07 | 934 | 150 | 18 | 33916271 |
| Pubmed | 2.65e-07 | 266 | 150 | 10 | 19380743 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | DCAF1 AARS1 OGT SF3A1 MCC SPAG9 NEDD1 EHD3 RAD50 DNAAF2 NEFM NEFL MB21D2 EML5 PDRG1 DDHD1 EIF2B5 CEP131 LNPK TP53 SOAT1 | 2.68e-07 | 1321 | 150 | 21 | 27173435 |
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 15797458 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 34689350 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 18978522 | ||
| Pubmed | 3.14e-07 | 4 | 150 | 3 | 9480752 | ||
| Pubmed | 3.23e-07 | 63 | 150 | 6 | 16831889 | ||
| Pubmed | 4.35e-07 | 215 | 150 | 9 | 35973513 | ||
| Pubmed | 4.37e-07 | 15 | 150 | 4 | 14697343 | ||
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 4.68e-07 | 67 | 150 | 6 | 21875946 | |
| Pubmed | Comprehensive analysis of keratin gene clusters in humans and rodents. | 5.81e-07 | 16 | 150 | 4 | 15085952 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 6.25e-07 | 38 | 150 | 5 | 12791264 | |
| Pubmed | Transcription factor Foxp3 and its protein partners form a complex regulatory network. | RGPD4 DHX36 RANBP2 RGPD8 RBBP5 PFKL TBL3 RGPD3 IK CTPS1 TP53 | 6.79e-07 | 370 | 150 | 11 | 22922362 |
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 24168324 | ||
| Pubmed | Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. | 7.81e-07 | 5 | 150 | 3 | 11266076 | |
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 11093772 | ||
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 14559847 | ||
| Pubmed | 7.81e-07 | 5 | 150 | 3 | 23383134 | ||
| Pubmed | DHX36 AARS1 OGT RBBP5 DIDO1 PFKL ANKRD27 PTK2 FREM2 SBF1 DDHD1 EIF2B5 AACS OGFOD1 | 9.60e-07 | 650 | 150 | 14 | 38777146 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | DCAF1 DHX36 RANBP2 AARS1 MYO1C NPEPPS TTC27 PFKL ANKRD27 TBL3 PTK2 RAD50 DHX15 METTL13 SBF1 MTHFD1 EIF2B5 MACF1 IK CTPS1 | 1.62e-06 | 1353 | 150 | 20 | 29467282 |
| Pubmed | DCAF1 DOCK4 RAP1GAP2 ZHX2 EPM2AIP1 TENM3 BTBD7 OGFOD1 MACF1 PPIP5K1 PLXNB3 | 1.71e-06 | 407 | 150 | 11 | 12693553 | |
| Pubmed | AARS1 OGT RBBP5 NPEPPS SF3A1 SPAG9 PFKL TBL3 DHX15 MTHFD1 STIP1 CTPS1 | 1.73e-06 | 494 | 150 | 12 | 26831064 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 DHX36 RANBP2 OGT RGPD8 MYO1C NPEPPS TTC27 GCDH PFKL TBL3 DHX15 METTL13 MTHFD1 RGPD3 IK CTPS1 CKMT1A RGPD5 | 2.19e-06 | 1257 | 150 | 19 | 37317656 |
| Pubmed | 2.29e-06 | 22 | 150 | 4 | 27717094 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | KCTD12 RANBP2 AARS1 OGT NPEPPS SF3A1 SPAG9 PFKL RAD50 DHX15 NEFM NEFL PDRG1 MTHFD1 MACF1 STIP1 CTPS1 TP53 | 2.52e-06 | 1149 | 150 | 18 | 35446349 |
| Pubmed | The human cytochrome P450 3A locus. Gene evolution by capture of downstream exons. | 2.72e-06 | 7 | 150 | 3 | 11137287 | |
| Pubmed | 2.72e-06 | 7 | 150 | 3 | 25639508 | ||
| Pubmed | 2.72e-06 | 7 | 150 | 3 | 19842932 | ||
| Pubmed | 4.32e-06 | 284 | 150 | 9 | 29459677 | ||
| Pubmed | 4.33e-06 | 8 | 150 | 3 | 20147896 | ||
| Pubmed | 4.69e-06 | 99 | 150 | 6 | 27746211 | ||
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 4.83e-06 | 153 | 150 | 7 | 26365490 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | TEAD2 RANBP2 OGT RBBP5 SF3A1 NUP98 SPAG9 E2F6 PFKL RAD50 NEFM DES METTL13 TMF1 TP53 | 4.94e-06 | 857 | 150 | 15 | 25609649 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | RGPD4 RANBP2 AARS1 MYO1C NPEPPS TTC27 GCDH PFKL DES MTHFD1 CTPS1 TP53 CKMT1A | 5.06e-06 | 647 | 150 | 13 | 26618866 |
| Interaction | KRT19 interactions | KRT78 KRT16 KRT81 KRT83 KRT85 KRT86 CCDC77 CEP164 CRK BFSP1 NEFM DES SIRT2 CEP131 | 2.20e-08 | 282 | 148 | 14 | int:KRT19 |
| Interaction | KRT37 interactions | 5.24e-08 | 100 | 148 | 9 | int:KRT37 | |
| Interaction | KRT35 interactions | 1.30e-07 | 111 | 148 | 9 | int:KRT35 | |
| Interaction | KRT16 interactions | KRT78 KRT16 KRT81 KRT83 KRT85 KRT86 CRK EPM2AIP1 NEFM DES TP53 | 2.35e-07 | 197 | 148 | 11 | int:KRT16 |
| Interaction | KRT33B interactions | 4.21e-07 | 93 | 148 | 8 | int:KRT33B | |
| Interaction | RGPD4 interactions | 4.75e-07 | 22 | 148 | 5 | int:RGPD4 | |
| Interaction | C2CD4B interactions | 7.95e-07 | 44 | 148 | 6 | int:C2CD4B | |
| Interaction | ADAMTS13 interactions | 1.16e-06 | 26 | 148 | 5 | int:ADAMTS13 | |
| Interaction | RGPD2 interactions | 1.41e-06 | 27 | 148 | 5 | int:RGPD2 | |
| Interaction | RGPD1 interactions | 1.53e-06 | 49 | 148 | 6 | int:RGPD1 | |
| Interaction | KRT14 interactions | 1.59e-06 | 192 | 148 | 10 | int:KRT14 | |
| Interaction | OFD1 interactions | KRT81 KRT83 KRT86 CCDC77 NEDD1 CEP164 PTK2 RAD50 PDRG1 CEP131 STIP1 CTPS1 TP53 | 1.77e-06 | 347 | 148 | 13 | int:OFD1 |
| Interaction | SIRT7 interactions | DCAF1 DHX36 RANBP2 AARS1 MYO1C NPEPPS SF3A1 NUP98 DIDO1 SPAG9 TBL3 RAD50 DHX15 NEFM NEFL SBF1 MACF1 IK TP53 | 2.31e-06 | 744 | 148 | 19 | int:SIRT7 |
| Interaction | KRT27 interactions | 2.51e-06 | 202 | 148 | 10 | int:KRT27 | |
| Interaction | RANBP2 interactions | RGPD4 RANBP2 RGPD8 DCPS NUP98 RAD50 TAOK2 DHX15 RGPD3 STIP1 IK TP53 RGPD5 | 2.73e-06 | 361 | 148 | 13 | int:RANBP2 |
| Interaction | SCUBE1 interactions | 3.84e-06 | 5 | 148 | 3 | int:SCUBE1 | |
| Interaction | KRT39 interactions | 4.63e-06 | 59 | 148 | 6 | int:KRT39 | |
| Interaction | KRT25 interactions | 5.43e-06 | 35 | 148 | 5 | int:KRT25 | |
| Interaction | KRT15 interactions | 6.83e-06 | 178 | 148 | 9 | int:KRT15 | |
| Interaction | RICTOR interactions | RGPD4 DHX36 AARS1 KRT78 KRT16 RGPD8 MYO1C SF3A1 KRT86 TRIM52 CRK DHX15 SIRT2 MTHFD1 RGPD3 LNPK IK RGPD5 | 1.20e-05 | 759 | 148 | 18 | int:RICTOR |
| Interaction | BICD1 interactions | 1.64e-05 | 250 | 148 | 10 | int:BICD1 | |
| Interaction | RGPD8 interactions | 1.74e-05 | 74 | 148 | 6 | int:RGPD8 | |
| Interaction | KRT36 interactions | 1.74e-05 | 74 | 148 | 6 | int:KRT36 | |
| Interaction | KRT8 interactions | DOCK4 OGT KRT16 CCDC77 CRK NEFM DES NEFL SIRT2 CEP131 DEDD PCDH7 TP53 | 2.32e-05 | 441 | 148 | 13 | int:KRT8 |
| Interaction | SASS6 interactions | 2.33e-05 | 159 | 148 | 8 | int:SASS6 | |
| Interaction | SUPT16H interactions | TEAD2 RANBP2 DCPS RBBP5 SF3A1 CEP164 DHX15 SBF1 GOLGA7 RASD1 STIP1 IK TP53 | 2.38e-05 | 442 | 148 | 13 | int:SUPT16H |
| Interaction | RGPD3 interactions | 2.39e-05 | 47 | 148 | 5 | int:RGPD3 | |
| Interaction | ZWINT interactions | 2.44e-05 | 160 | 148 | 8 | int:ZWINT | |
| Interaction | KRT31 interactions | KRT78 KRT81 KRT83 KRT85 KRT86 BAK1 HAPLN2 BFSP1 NEFM NEFL PRR35 SUV39H1 HCK | 3.07e-05 | 453 | 148 | 13 | int:KRT31 |
| Interaction | NUP62 interactions | 3.48e-05 | 273 | 148 | 10 | int:NUP62 | |
| Interaction | KRT38 interactions | 4.09e-05 | 172 | 148 | 8 | int:KRT38 | |
| Interaction | CCDC92 interactions | 4.31e-05 | 53 | 148 | 5 | int:CCDC92 | |
| Interaction | PHF21A interactions | RANBP2 OGT TTC27 E2F6 CRK RAD50 NEFM TMF1 CEP131 PCCA CSTPP1 | 4.75e-05 | 343 | 148 | 11 | int:PHF21A |
| Interaction | KRT2 interactions | 6.36e-05 | 236 | 148 | 9 | int:KRT2 | |
| Interaction | KRT18 interactions | KRT16 KRT81 MCC CCDC77 DHX15 NEFM DES NEFL CEP131 DEDD DNAJC3 PCDH7 | 6.38e-05 | 419 | 148 | 12 | int:KRT18 |
| Interaction | RGPD5 interactions | 7.63e-05 | 96 | 148 | 6 | int:RGPD5 | |
| Interaction | CYP3A5 interactions | 8.13e-05 | 12 | 148 | 3 | int:CYP3A5 | |
| Interaction | KIF20A interactions | RGPD4 RANBP2 RGPD8 MYO1C NUP98 DIDO1 SPAG9 TBL3 ITIH4 DHX15 NEFM DES NEFL RGPD3 EIF2B5 MACF1 PPIP5K1 IK TRPV5 TP53 | 8.90e-05 | 1052 | 148 | 20 | int:KIF20A |
| Interaction | BIRC3 interactions | KCTD12 DHX36 RANBP2 AARS1 ATP8B4 MYO1C RBBP5 NPEPPS SF3A1 NUP98 PFKL F2 TBL3 RBCK1 RAD50 DHX15 MTHFD1 STIP1 TDRD6 IK CTPS1 TP53 CKMT1A | 1.11e-04 | 1334 | 148 | 23 | int:BIRC3 |
| Interaction | RCC1 interactions | 1.22e-04 | 201 | 148 | 8 | int:RCC1 | |
| Interaction | SYNC interactions | 1.34e-04 | 67 | 148 | 5 | int:SYNC | |
| Interaction | EED interactions | DCAF1 DHX36 RANBP2 AARS1 OGT DCPS MYO1C SF3A1 OBSCN NUP98 TTC27 DIDO1 E2F6 PFKL TBL3 RAD50 DHX15 SIRT2 MB21D2 MTHFD1 MACF1 IK CTPS1 SOAT1 | 1.37e-04 | 1445 | 148 | 24 | int:EED |
| Interaction | CIT interactions | DHX36 RANBP2 AARS1 MYO1C RBBP5 NPEPPS SF3A1 NUP98 DIDO1 E2F6 PFKL TBL3 ITIH4 BFSP1 DHX15 NEFM DES NEFL SUV39H1 RGPD3 MACF1 IK TRPV5 TP53 | 1.45e-04 | 1450 | 148 | 24 | int:CIT |
| Interaction | COP1 interactions | 1.52e-04 | 326 | 148 | 10 | int:COP1 | |
| Interaction | TOP2B interactions | 1.58e-04 | 266 | 148 | 9 | int:TOP2B | |
| Interaction | HDAC1 interactions | DCAF1 RANBP2 OGT RBBP5 SF3A1 NUP98 TTC27 SPAG9 E2F6 ZHX2 CRK RAD50 NEFM SUV39H1 TMF1 CEP131 STIP1 PCCA TP53 CSTPP1 | 1.78e-04 | 1108 | 148 | 20 | int:HDAC1 |
| Interaction | NUMA1 interactions | RANBP2 KRT78 OGT RBBP5 DNAH2 NUP98 CRK RAD50 SUV39H1 RGPD3 MACF1 TP53 | 1.84e-04 | 469 | 148 | 12 | int:NUMA1 |
| Interaction | PXN interactions | 1.85e-04 | 334 | 148 | 10 | int:PXN | |
| Interaction | PRRG4 interactions | 1.88e-04 | 39 | 148 | 4 | int:PRRG4 | |
| Interaction | KDM1A interactions | RANBP2 OGT RBBP5 TTC27 E2F6 CRK RAD50 DHX15 NEFM NEFL SUV39H1 TMF1 CEP131 STIP1 IK PCCA TP53 CSTPP1 | 1.91e-04 | 941 | 148 | 18 | int:KDM1A |
| Interaction | RAN interactions | RGPD4 RANBP2 OGT RGPD8 RBBP5 NUP98 DHX15 SIRT2 RGPD3 STIP1 TP53 RGPD5 | 2.06e-04 | 475 | 148 | 12 | int:RAN |
| Interaction | TSKS interactions | 2.08e-04 | 40 | 148 | 4 | int:TSKS | |
| Interaction | HTT interactions | KCTD12 OGT NPEPPS PFKL OGN PTK2 RBCK1 EHD3 DHX15 NEFM NEFL SIRT2 MTHFD1 AOC3 TDRD6 TSKS HCK TP53 | 2.12e-04 | 949 | 148 | 18 | int:HTT |
| Interaction | HDAC2 interactions | DCAF1 AARS1 KRT78 OGT KRT16 DCPS RBBP5 CCDC174 SPAG9 E2F6 PFKL ZHX2 DHX15 SUV39H1 STIP1 CTPS1 TP53 | 2.12e-04 | 865 | 148 | 17 | int:HDAC2 |
| Interaction | XAGE1A interactions | 2.29e-04 | 41 | 148 | 4 | int:XAGE1A | |
| Interaction | LAG3 interactions | 2.45e-04 | 17 | 148 | 3 | int:LAG3 | |
| Interaction | KRT34 interactions | 2.50e-04 | 283 | 148 | 9 | int:KRT34 | |
| Interaction | NPIPB6 interactions | 2.92e-04 | 18 | 148 | 3 | int:NPIPB6 | |
| Interaction | RCOR1 interactions | RANBP2 OGT LAMB2 SPAG9 E2F6 CRK RAD50 NEFM TMF1 CEP131 PCCA CSTPP1 | 2.95e-04 | 494 | 148 | 12 | int:RCOR1 |
| Interaction | HPCA interactions | 3.02e-04 | 44 | 148 | 4 | int:HPCA | |
| Interaction | NAA40 interactions | KCTD12 RANBP2 AARS1 SF3A1 NUP98 DIDO1 SPAG9 PFKL NEDD1 RAD50 SIRT2 MTHFD1 MACF1 STIP1 CTPS1 PCCA TP53 CSTPP1 | 3.05e-04 | 978 | 148 | 18 | int:NAA40 |
| Interaction | SCUBE2 interactions | 3.18e-04 | 4 | 148 | 2 | int:SCUBE2 | |
| Interaction | CEP128 interactions | 3.56e-04 | 297 | 148 | 9 | int:CEP128 | |
| Interaction | FLT1 interactions | 3.62e-04 | 179 | 148 | 7 | int:FLT1 | |
| Interaction | NPHP4 interactions | 3.63e-04 | 236 | 148 | 8 | int:NPHP4 | |
| Interaction | EEF1AKMT3 interactions | WDR81 ANKRD27 RBCK1 RAD50 METTL13 SBF1 AACS PPIP5K1 STIP1 RGPD5 | 3.67e-04 | 364 | 148 | 10 | int:EEF1AKMT3 |
| Interaction | PCM1 interactions | KCTD12 KRT16 KRT81 KRT83 KRT86 CCDC77 NEDD1 CEP164 BFSP1 CEP131 CSTPP1 | 3.71e-04 | 434 | 148 | 11 | int:PCM1 |
| Interaction | PLD1 interactions | 4.00e-04 | 130 | 148 | 6 | int:PLD1 | |
| Interaction | ASNS interactions | 4.27e-04 | 184 | 148 | 7 | int:ASNS | |
| Cytoband | 12q13 | 8.97e-05 | 71 | 150 | 4 | 12q13 | |
| Cytoband | 17p13.3 | 2.06e-04 | 88 | 150 | 4 | 17p13.3 | |
| Cytoband | 7q21.1 | 2.93e-04 | 8 | 150 | 2 | 7q21.1 | |
| Cytoband | 15q15 | 6.85e-04 | 12 | 150 | 2 | 15q15 | |
| Cytoband | 2q31 | 8.08e-04 | 13 | 150 | 2 | 2q31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 1.01e-03 | 346 | 150 | 6 | chr17p13 | |
| Cytoband | 2q12.3 | 1.40e-03 | 17 | 150 | 2 | 2q12.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr15q15 | 1.42e-03 | 147 | 150 | 4 | chr15q15 | |
| Cytoband | 2q13 | 1.47e-03 | 68 | 150 | 3 | 2q13 | |
| Cytoband | 8p21 | 1.94e-03 | 20 | 150 | 2 | 8p21 | |
| Cytoband | 20p12.1 | 3.03e-03 | 25 | 150 | 2 | 20p12.1 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 1.11e-08 | 115 | 97 | 9 | 769 | |
| GeneFamily | Keratins, type II | 2.94e-07 | 27 | 97 | 5 | 609 | |
| GeneFamily | Cytochrome P450 family 3 | 8.22e-06 | 8 | 97 | 3 | 1002 | |
| GeneFamily | Intermediate filaments Type IV | 4.21e-04 | 6 | 97 | 2 | 611 | |
| GeneFamily | SH2 domain containing | 2.14e-03 | 101 | 97 | 4 | 741 | |
| GeneFamily | WD repeat domain containing | 2.88e-03 | 262 | 97 | 6 | 362 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 2.92e-03 | 181 | 97 | 5 | 694 | |
| GeneFamily | DEAH-box helicases | 3.26e-03 | 16 | 97 | 2 | 500 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 4.49e-06 | 43 | 149 | 5 | MM3857 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_200 | 1.75e-05 | 162 | 147 | 8 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_200 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-07 | 181 | 150 | 8 | 429df38438d5a7ff490c9ede34b69e2970c7ded2 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.90e-07 | 181 | 150 | 8 | 395cf5aa2d89b05328ab516b8c89401020b6d830 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-06 | 172 | 150 | 7 | 073a503dc922e3e3ac3528e249b0f8b74402110b | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-06 | 178 | 150 | 7 | 416f85e51f45ec7949451fd47611a84e33e87245 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.29e-06 | 186 | 150 | 7 | 56c139e679d640ea901ead657a8e8887e0fca098 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|Adult / Lineage, Cell type, age group and donor | 3.54e-06 | 188 | 150 | 7 | e5cad03f4a64147fe8174e7f614cf45233ffb9b7 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.54e-06 | 188 | 150 | 7 | d1a4cd4db95d8d32b79156290f7867f32824cc87 | |
| ToppCell | droplet-Kidney-nan-21m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.79e-06 | 190 | 150 | 7 | e04f47705851563515b6a66a2634cf7a574f7bda | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.06e-06 | 192 | 150 | 7 | 26d9207e72bbef5e0046de511e2c9ff752b726f3 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.06e-06 | 192 | 150 | 7 | eb9a0b3d32f90f8b95905c740aab21639dae5cbd | |
| ToppCell | P15-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.06e-06 | 192 | 150 | 7 | a476895b7b252c388d6346eacbc72f0115b1443e | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.20e-06 | 193 | 150 | 7 | 9a2c1711dec9dd8c8313bcf25bb888ac8e86c3f3 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.20e-06 | 193 | 150 | 7 | 7fc3ab7261c88c1df71744bf5b17e8e46c4300e0 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.20e-06 | 193 | 150 | 7 | 7c7aa5e2124830d0fa1df11b6413ec6cf780aad0 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-06 | 194 | 150 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Tumor-Diffuse_large_B-cell_lymphoma-DLBCL-1|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 4.35e-06 | 194 | 150 | 7 | eaeeb84576270cc3fc59002ba33bff9639bb0b02 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-06 | 196 | 150 | 7 | 9a90dd26e7a43e3fd55e7c5d8354cfa4cdd5a6cc | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.65e-06 | 196 | 150 | 7 | 04dfef1bd4ebb0e9469ae80024dc177e469a2560 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.81e-06 | 197 | 150 | 7 | 1a6b2ca94a4634c24cd95481576c955b20000a5f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.81e-06 | 197 | 150 | 7 | 78d45d11820ec379942c4c3defd619d5f8cc8e1f | |
| ToppCell | 343B-Fibroblasts-Fibroblast-K_(Pericytes)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.81e-06 | 197 | 150 | 7 | 31bc9fd679d78550541d4158568e8dd09ff29e8e | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-06 | 197 | 150 | 7 | 488e85991c5e668afb7672942726d9295b8fc7d8 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 5.14e-06 | 199 | 150 | 7 | 056a28c36cd58dc695a5ae6f29b62135d6aad819 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.75e-06 | 142 | 150 | 6 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.75e-06 | 142 | 150 | 6 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_pDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.20e-05 | 167 | 150 | 6 | 8ddf9da71a7c4ed53588435db826563a24cee616 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-05 | 170 | 150 | 6 | 17bd7fd25a2657cb536ad47e294332920f759e95 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-TRGV4_gdT|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-05 | 170 | 150 | 6 | 65c7ed586e7615203a59999549892ed466a89502 | |
| ToppCell | COPD-Lymphoid-ILC_A|Lymphoid / Disease state, Lineage and Cell class | 2.68e-05 | 173 | 150 | 6 | 4a0043b29f8ede5a74bdb38cbf2c70e12b25e130 | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.72e-05 | 104 | 150 | 5 | a4ae3cae44aac8b6e0d14896f9acab44f0cc97c4 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 176 | 150 | 6 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 176 | 150 | 6 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-05 | 177 | 150 | 6 | dbdbdc8ed9ef0b529694242ef9f9f07a42e16005 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-05 | 178 | 150 | 6 | 6178706db4a855d72abc156537604d575624df56 | |
| ToppCell | 343B-Lymphocytic-NK_cells-Proliferating_NK_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.15e-05 | 178 | 150 | 6 | c7e890cd02206c516cf1d7692ea7abc8ce746482 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.15e-05 | 178 | 150 | 6 | f02076ece0fa899e620971c887ad4da7f48684ed | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 179 | 150 | 6 | 8da6863edc756540bb097cc7221c1408640d9bb4 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 179 | 150 | 6 | d76a05f1fee7f2f7b7b7994d3622e96f02b49432 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 179 | 150 | 6 | 6be47c877250968a916c711ba0787eb7b4c5443d | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.25e-05 | 179 | 150 | 6 | f39c13c99a07d009cc677e363ffe089089c64916 | |
| ToppCell | FF-Differ-KC|World / shred by cell class for mouse tongue | 3.25e-05 | 179 | 150 | 6 | 1526a130565a97c291a25a7a988089bffc1515c1 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.35e-05 | 180 | 150 | 6 | 455d1e3ccf2ab609954f3b870e8f514ddca735f4 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 181 | 150 | 6 | 4df7972f88117108698efd06b124b232f8588981 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.45e-05 | 181 | 150 | 6 | cbb530566893281289026bfd93adf721decd4ca3 | |
| ToppCell | Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D175|Adult / Lineage, Cell type, age group and donor | 3.56e-05 | 182 | 150 | 6 | 8b4a07ebd7a133a33ef333cfa29d12c4f3d4d9ac | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.67e-05 | 183 | 150 | 6 | ba43bca2b45be1008eebd3f033cecb061fb3a966 | |
| ToppCell | LPS-IL1RA|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.79e-05 | 184 | 150 | 6 | c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-4|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 3.79e-05 | 184 | 150 | 6 | 67164bb6bcae7322cb89b585c7aa10bce35b0ecd | |
| ToppCell | E17.5-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.14e-05 | 187 | 150 | 6 | 0dee138738b65531ff134a125b92234b5d0a653c | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.27e-05 | 188 | 150 | 6 | 789d1be574e693d7bdd488f3c72c6df788e47b47 | |
| ToppCell | P07-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.27e-05 | 188 | 150 | 6 | 6ec22b79b19d57ea187f312907819dc2d01f3efe | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.40e-05 | 189 | 150 | 6 | 5c85656f555d91ecc9540faa67717694a4aef92f | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.40e-05 | 189 | 150 | 6 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | P03-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.40e-05 | 189 | 150 | 6 | b5439ef221106f6d54434f268485e9bb17b39102 | |
| ToppCell | droplet-Tongue-nan-3m-Epithelial-filiform|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-05 | 190 | 150 | 6 | 251e3a33041023bfc4b547c7eb68cfb8f421636f | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.53e-05 | 190 | 150 | 6 | 0a351609a72fd638c84b2435782e312ee6a33aac | |
| ToppCell | Mesenchymal_cells-Smooth_muscle|World / Lineage and Cell class | 4.53e-05 | 190 | 150 | 6 | 5aa62a363a25f4a110136263b21289a11e8c1e6d | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.53e-05 | 190 | 150 | 6 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.66e-05 | 191 | 150 | 6 | 5c1f5b6c115b1b27b4a7467a6550ce43c01cf6d0 | |
| ToppCell | Control-Stromal-SMC|Stromal / Disease state, Lineage and Cell class | 4.66e-05 | 191 | 150 | 6 | 2da83c493e60ad0278848957645277d76737a188 | |
| ToppCell | P28-Mesenchymal-myocytic_cell-vascular_associated_smooth_muscle_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.80e-05 | 192 | 150 | 6 | 87c7780cf72f4c204f2a5f6655309d47a23c08ae | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 193 | 150 | 6 | 1043b28503bfaa0d5a82ec358bc86cbde73ea8f2 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 193 | 150 | 6 | 3a5090f81f35026f435f4a250d1e77601a53af15 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.94e-05 | 193 | 150 | 6 | 5260ac95a15cc43a19909badad0c7e3854da920d | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.94e-05 | 193 | 150 | 6 | 88916d9a7d831eb52848599917c04238f8f9812b | |
| ToppCell | droplet-Bladder-nan-3m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 193 | 150 | 6 | 8be24713f8ba2545b7647d1994e9e993623ddaa3 | |
| ToppCell | droplet-Bladder-nan-3m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 193 | 150 | 6 | 19dfc4a2c91fcea4f5991e7c44df46faeecb06b8 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 193 | 150 | 6 | 13731b7fc1e3bec0cebc44bad7e2ecea358bb76a | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 193 | 150 | 6 | 2483bb7f398e4fa0ef09c8bd584ed25703853f03 | |
| ToppCell | droplet-Bladder-nan-3m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 193 | 150 | 6 | 351e0acd411a9eb0dbc0e358d0d1e3759753fa40 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 193 | 150 | 6 | 88cd7d0d0da5c776b49fc131f746fe5ad9676fb7 | |
| ToppCell | T_cells-CD56_bright_CD16-_NK_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 4.94e-05 | 193 | 150 | 6 | 826457e2aafdb61ead8a0a44d8cf9088d310684b | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.94e-05 | 193 | 150 | 6 | 0266a4fdf436d83ec1d9392abba8c6ec5166970a | |
| ToppCell | 368C-Fibroblasts-Fibroblast-K_(Pericytes)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.94e-05 | 193 | 150 | 6 | 5ec917931b438dd0e7fb03eb6af459d3ef6b84ba | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.94e-05 | 193 | 150 | 6 | 0256e8fe4a47f2e2a43ef9d19bfc047d20806d69 | |
| ToppCell | P28-Mesenchymal-myocytic_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.08e-05 | 194 | 150 | 6 | 83e45441c74b7f50b6725876b583229280179dc2 | |
| ToppCell | droplet-Bladder-Unstain-18m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 194 | 150 | 6 | 9d7cbbcf995274019ca10be0562f114513ec197a | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-Pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 194 | 150 | 6 | 3bff2e4eb16719ab7419b2f94c9c6e7302aa6629 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.08e-05 | 194 | 150 | 6 | aaecde88bd54134a938e76cdf059c1c2653e4e77 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Mesenchymal-brain_pericyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.08e-05 | 194 | 150 | 6 | fdaf61cbe7f77ff5358d150b38adb1fe3778e961 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.23e-05 | 195 | 150 | 6 | 8a04f0e92d10a368ccda5f566ae67ef51f1d34a9 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-MK-early_MK|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 5.23e-05 | 195 | 150 | 6 | fa5fc6f605deb5cae96eec14ba4000b19f877ba6 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.23e-05 | 195 | 150 | 6 | 56e7cd980f8fc2dae842e6a7bd919d4b41cebbbb | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.23e-05 | 195 | 150 | 6 | a28a504c69bc4dda7de023e1b4ea4f62390b158e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.38e-05 | 196 | 150 | 6 | 65d882c6e7f6d5778b8a5fd4fdaf012e1b9f6100 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.38e-05 | 196 | 150 | 6 | c390ef0adff35111989a30dff86b7c5db1a89873 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.38e-05 | 196 | 150 | 6 | 2f76f050083483f0880639e6c34ff349caac3503 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.38e-05 | 196 | 150 | 6 | 4740ef6e428f1ccc81fc98c3b868afd38ce60535 | |
| ToppCell | PBMC-Control-cDC_3|Control / Compartment, Disease Groups and Clusters | 5.38e-05 | 196 | 150 | 6 | 09d197b321ff9f13c0672ea059c850845b0dbbd5 | |
| ToppCell | mLN-B_cell-B_cell_cycling|mLN / Region, Cell class and subclass | 5.53e-05 | 197 | 150 | 6 | 806dddcca85c82bd642008d930c8db16b613d88e | |
| ToppCell | mLN-(2)_B_cell-(24)_B_cell_cycling|mLN / shred on region, Cell_type, and subtype | 5.53e-05 | 197 | 150 | 6 | 70fff2d6723f259e18e7a21d22dc46d71f0759ce | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 5.53e-05 | 197 | 150 | 6 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 5.69e-05 | 198 | 150 | 6 | 0c4d2c68a42f8a9e964e2dd28092fe75f5216834 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Radial_glial-RGCs_3|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 5.85e-05 | 199 | 150 | 6 | 79d87e2b0adeff2d33c3b699afe7211fddc4f285 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial-Proteoglycan-expressing_cell|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 6.02e-05 | 200 | 150 | 6 | aafe594c88710f8c53d59667cdac5035e08f5511 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW19-Neuroepithelial|GW19 / Sample Type, Dataset, Time_group, and Cell type. | 6.02e-05 | 200 | 150 | 6 | a6f0f5f644b7262878b0b9d4d90ee407c4124dd9 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-neuroepithelial-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 7.06e-05 | 127 | 150 | 5 | 9071cd0953c8bb6746dc9cd13d153e3d6ef40b08 | |
| ToppCell | LPS-IL1RA+antiTNF-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.79e-05 | 133 | 150 | 5 | 81189e8516a431d5890a0909f9fc7c82ec3442bc | |
| ToppCell | Globus_pallidus-Macroglia-POLYDENDROCYTE-P1|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.01e-04 | 137 | 150 | 5 | 80f1a6cfb48ccfba1c3545fdcd5fcb3157272aca | |
| ToppCell | LPS-IL1RA-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.28e-04 | 144 | 150 | 5 | 7c471e332f87d60f4dbed01f3e66bf39995218d0 | |
| Computational | Genes in the cancer module 68. | 6.23e-05 | 26 | 91 | 4 | MODULE_68 | |
| Computational | Keratin. | 6.23e-05 | 26 | 91 | 4 | MODULE_298 | |
| Drug | amodiaquine | 6.62e-09 | 40 | 148 | 7 | CID000002165 | |
| Drug | bisdesethylchloroquine | 2.11e-07 | 9 | 148 | 4 | CID000122672 | |
| Drug | territrem C | 2.69e-07 | 3 | 148 | 3 | CID000160306 | |
| Drug | territrem B | 1.07e-06 | 4 | 148 | 3 | CID000114734 | |
| Drug | propionanilide | 1.63e-06 | 14 | 148 | 4 | CID000012107 | |
| Drug | 2,4,5-trichlorophenol | 1.69e-06 | 56 | 148 | 6 | CID000007271 | |
| Drug | ethylbenzene | 2.55e-06 | 60 | 148 | 6 | CID000007500 | |
| Drug | ethyl isocyanate | 2.67e-06 | 5 | 148 | 3 | CID000008022 | |
| Drug | noralfentanil | 3.82e-06 | 17 | 148 | 4 | CID000162172 | |
| Drug | Alfentanil | 5.31e-06 | 6 | 148 | 3 | ctd:D015760 | |
| Drug | CID5475388 | 7.66e-06 | 20 | 148 | 4 | CID005475388 | |
| Drug | artemether | 7.66e-06 | 20 | 148 | 4 | CID000068911 | |
| Drug | cycloguanil | 7.66e-06 | 20 | 148 | 4 | CID000009048 | |
| Drug | choline | TEAD2 KRT81 KRT83 SPAG9 F2 MTHFD1 ETNK2 EIF2B5 PLCB2 TP53 CKMT1A | 8.23e-06 | 320 | 148 | 11 | CID000000305 |
| Drug | 4-formylbiphenyl | 9.24e-06 | 7 | 148 | 3 | CID000076689 | |
| Drug | 4-(4-chlorobenzyl)pyridine | 9.24e-06 | 7 | 148 | 3 | CID000078124 | |
| Drug | 2beta-hydroxytestosterone | 9.24e-06 | 7 | 148 | 3 | CID005207588 | |
| Drug | pentachlorophenol | 1.37e-05 | 120 | 148 | 7 | CID000000992 | |
| Drug | AC1L2K1Q | 1.38e-05 | 23 | 148 | 4 | CID000022258 | |
| Drug | nafimidone | 1.47e-05 | 8 | 148 | 3 | CID000051199 | |
| Drug | diethylformamide | 1.47e-05 | 8 | 148 | 3 | CID000012051 | |
| Drug | L-754394 | 1.47e-05 | 8 | 148 | 3 | CID000153982 | |
| Drug | AC1MI0E8 | 1.47e-05 | 8 | 148 | 3 | CID003036008 | |
| Drug | desethylchloroquine | 1.47e-05 | 8 | 148 | 3 | CID000095478 | |
| Drug | teleocidin B | 1.61e-05 | 123 | 148 | 7 | CID000072425 | |
| Drug | Flame Retardants | 1.77e-05 | 226 | 148 | 9 | ctd:D005411 | |
| Drug | PD138142-15 | 2.20e-05 | 9 | 148 | 3 | CID003025787 | |
| Drug | aflatoxin B1-8,9-epoxide | 2.20e-05 | 9 | 148 | 3 | CID000104756 | |
| Drug | S 840 | 2.20e-05 | 9 | 148 | 3 | CID000096338 | |
| Drug | Fluorouracil | KCTD12 AARS1 KRT16 CYP3A4 UNC5B KRT86 BAK1 HAPLN2 F2 PTK2 CRK DHX15 DES SCUBE2 CDCA7 GUCY1B1 NBPF10 MACF1 BCAR3 CTPS1 CDH5 TP53 SOAT1 | 2.43e-05 | 1364 | 148 | 23 | ctd:D005472 |
| Drug | AC1L1CGL | 2.68e-05 | 27 | 148 | 4 | CID000001889 | |
| Drug | dimethyl sulfide | 2.90e-05 | 55 | 148 | 5 | CID000001068 | |
| Drug | 4-hydroxymidazolam | 3.12e-05 | 10 | 148 | 3 | CID000124449 | |
| Drug | perillyl alcohol | 3.17e-05 | 56 | 148 | 5 | CID000010819 | |
| Drug | econazole | 3.46e-05 | 57 | 148 | 5 | CID000003198 | |
| Drug | bilobalide | 4.12e-05 | 30 | 148 | 4 | CID000073581 | |
| Drug | dihydroartemisinin | 4.12e-05 | 30 | 148 | 4 | CID000107770 | |
| Drug | 4-hydroxymidazolam | 4.20e-05 | 2 | 148 | 2 | ctd:C042940 | |
| Drug | Benzo[b]phenanthro[2,3-d]thiophene | 4.20e-05 | 2 | 148 | 2 | CID006428586 | |
| Drug | norverapamil | 4.20e-05 | 2 | 148 | 2 | ctd:C016904 | |
| Drug | 5,6-dihydro-2H-pyran-2-one | 4.20e-05 | 2 | 148 | 2 | CID000520660 | |
| Drug | notopterol | 4.20e-05 | 2 | 148 | 2 | CID005320227 | |
| Drug | melicopicine | 4.20e-05 | 2 | 148 | 2 | CID000101253 | |
| Drug | N-acetyl-S--(1,2,3,4,4-pentachlorobutadienyl)cysteine sulfoxide | 4.20e-05 | 2 | 148 | 2 | ctd:C114289 | |
| Drug | DEHP-CP | 4.20e-05 | 2 | 148 | 2 | CID000127131 | |
| Drug | tebuquine | 4.20e-05 | 2 | 148 | 2 | CID000071991 | |
| Drug | 3,5-di-O-galloylquinic acid | 4.20e-05 | 2 | 148 | 2 | CID000460896 | |
| Drug | 6 beta-hydroxytestosterone | 4.20e-05 | 2 | 148 | 2 | ctd:C025591 | |
| Drug | D-Myo-Inositol-1,4,5-Triphosphate | 4.20e-05 | 2 | 148 | 2 | DB03401 | |
| Drug | MADDS-NOH | 4.20e-05 | 2 | 148 | 2 | CID000169449 | |
| Drug | CQA 206-291 | 4.20e-05 | 2 | 148 | 2 | ctd:C059483 | |
| Drug | fructus schizandrae, radix ginseng, radix ophiopogonis drug combination | 4.20e-05 | 2 | 148 | 2 | ctd:C009252 | |
| Drug | phenindione | 4.27e-05 | 11 | 148 | 3 | CID000004760 | |
| Drug | Troleandomycin | 4.27e-05 | 11 | 148 | 3 | ctd:D014217 | |
| Drug | Ticalopride | 4.27e-05 | 11 | 148 | 3 | CID000216236 | |
| Drug | Edrophonium chloride [116-38-1]; Down 200; 19.8uM; HL60; HG-U133A | 4.40e-05 | 196 | 148 | 8 | 2019_DN | |
| Drug | AC1L1BIT | 4.44e-05 | 60 | 148 | 5 | CID000001457 | |
| Drug | AH23848 hemicalcium salt hydrate; Down 200; 1uM; MCF7; HT_HG-U133A | 4.57e-05 | 197 | 148 | 8 | 6903_DN | |
| Drug | (+)-Arteannuin | 4.81e-05 | 61 | 148 | 5 | CID000002240 | |
| Drug | Pargyline hydrochloride [306-07-0]; Up 200; 20.4uM; MCF7; HT_HG-U133A | 4.90e-05 | 199 | 148 | 8 | 7016_UP | |
| Drug | AC1L9IK6 | 5.35e-05 | 32 | 148 | 4 | CID000445780 | |
| Drug | AC1NRBWH | 5.67e-05 | 12 | 148 | 3 | CID005288678 | |
| Drug | N-hydroxyamphetamine | 5.67e-05 | 12 | 148 | 3 | CID000065546 | |
| Drug | 2-Tbmbfd | 5.67e-05 | 12 | 148 | 3 | CID000126928 | |
| Drug | 9-anthraldehyde | 5.67e-05 | 12 | 148 | 3 | CID000069504 | |
| Drug | atremon | 6.06e-05 | 33 | 148 | 4 | CID000002741 | |
| Drug | 5'-sulfamoyladenosine | 6.07e-05 | 64 | 148 | 5 | CID000097576 | |
| Drug | AC1L18GM | 7.34e-05 | 13 | 148 | 3 | CID000000092 | |
| Drug | UDP-4 | 7.34e-05 | 13 | 148 | 3 | CID000126618 | |
| Drug | arteether | 7.34e-05 | 13 | 148 | 3 | CID000072416 | |
| Drug | 4-chromanol | 7.67e-05 | 35 | 148 | 4 | CID000092890 | |
| Drug | 2,4-dichlorophenol | 7.67e-05 | 35 | 148 | 4 | CID000008449 | |
| Drug | 7-BFC | 9.30e-05 | 14 | 148 | 3 | CID000848780 | |
| Drug | 9-hydroxyellipticine | 9.30e-05 | 14 | 148 | 3 | CID000091643 | |
| Drug | 2-amino-3,4-dimethylimidazo(4,5-f)quinoline | 9.30e-05 | 14 | 148 | 3 | ctd:C036989 | |
| Drug | Hb 7 | 9.30e-05 | 14 | 148 | 3 | CID000128180 | |
| Drug | farnesylamine | 9.30e-05 | 14 | 148 | 3 | CID006449783 | |
| Drug | tetrachlorophenol | 9.30e-05 | 14 | 148 | 3 | CID000021013 | |
| Drug | dasatinib | 9.34e-05 | 70 | 148 | 5 | CID003062316 | |
| Drug | I5B1 | 9.58e-05 | 37 | 148 | 4 | CID005487705 | |
| Drug | imatinib | 1.21e-04 | 430 | 148 | 11 | CID000005291 | |
| Drug | chlorobenzene | 1.22e-04 | 74 | 148 | 5 | CID000007964 | |
| Drug | erythralosamine | 1.25e-04 | 3 | 148 | 2 | CID000352196 | |
| Drug | 5-hydroxytienilic acid | 1.25e-04 | 3 | 148 | 2 | CID000146269 | |
| Drug | 3-methoxymorphinan | 1.25e-04 | 3 | 148 | 2 | ctd:C028657 | |
| Drug | dechloroethylcyclophosphamide | 1.25e-04 | 3 | 148 | 2 | ctd:C064445 | |
| Drug | 6 beta-hydroxydexamethasone | 1.25e-04 | 3 | 148 | 2 | CID000063050 | |
| Drug | nitroxynil | 1.25e-04 | 3 | 148 | 2 | CID000015532 | |
| Drug | N-methylloline | 1.25e-04 | 3 | 148 | 2 | CID000168027 | |
| Drug | 17-hydroxypregnenolone sulfate | 1.25e-04 | 3 | 148 | 2 | CID000152971 | |
| Drug | sulfonamide-3 | 1.25e-04 | 3 | 148 | 2 | CID009847197 | |
| Drug | 2-nitroso-1-phenylpropane | 1.25e-04 | 3 | 148 | 2 | CID000124315 | |
| Drug | 1-hydroxymethylmidazolam | 1.25e-04 | 3 | 148 | 2 | ctd:C040081 | |
| Drug | trichloroguaiacol | 1.25e-04 | 3 | 148 | 2 | CID000042115 | |
| Drug | N-acetyl-S-pentachloro-1,3-butadienylcysteine | 1.25e-04 | 3 | 148 | 2 | ctd:C049739 | |
| Drug | 3-methylcholanthrene | 1.39e-04 | 231 | 148 | 8 | CID000001674 | |
| Drug | AC1L4VPA | 1.42e-04 | 16 | 148 | 3 | CID000164901 | |
| Drug | TTMS | 1.42e-04 | 16 | 148 | 3 | CID000007215 | |
| Drug | furafylline | 1.44e-04 | 41 | 148 | 4 | CID000003433 | |
| Drug | bosutinib | 1.58e-04 | 42 | 148 | 4 | CID005328940 | |
| Disease | MONILETHRIX | 1.09e-07 | 3 | 142 | 3 | 158000 | |
| Disease | Beaded hair | 1.09e-07 | 3 | 142 | 3 | cv:C0546966 | |
| Disease | monilethrix (is_implicated_in) | 1.09e-07 | 3 | 142 | 3 | DOID:0050472 (is_implicated_in) | |
| Disease | Monilethrix | 4.35e-07 | 4 | 142 | 3 | C0546966 | |
| Disease | tacrolimus measurement | 4.35e-07 | 4 | 142 | 3 | EFO_0008458 | |
| Disease | hair disease (is_implicated_in) | 2.30e-05 | 2 | 142 | 2 | DOID:421 (is_implicated_in) | |
| Disease | Charcot-Marie-Tooth disease | 4.99e-05 | 42 | 142 | 4 | cv:C0007959 | |
| Disease | metabolonic lactone sulfate measurement | 9.99e-05 | 19 | 142 | 3 | EFO_0800659 | |
| Disease | prothrombin measurement | 1.37e-04 | 4 | 142 | 2 | EFO_0020692 | |
| Disease | estrone conjugate measurement | 1.37e-04 | 4 | 142 | 2 | EFO_0007971 | |
| Disease | tyrosine-protein kinase TEC measurement | 1.37e-04 | 4 | 142 | 2 | EFO_0020830 | |
| Disease | tauro-beta-muricholate measurement | 2.28e-04 | 5 | 142 | 2 | EFO_0800213 | |
| Disease | glyco-beta-muricholate measurement | 2.28e-04 | 5 | 142 | 2 | EFO_0800569 | |
| Disease | X-12063 measurement | 2.91e-04 | 186 | 142 | 6 | EFO_0021283 | |
| Disease | intermittent claudication (biomarker_via_orthology) | 3.41e-04 | 6 | 142 | 2 | DOID:3669 (biomarker_via_orthology) | |
| Disease | Paratuberculosis | 3.41e-04 | 6 | 142 | 2 | C0030524 | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 3.41e-04 | 6 | 142 | 2 | EFO_0021119 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 3.41e-04 | 6 | 142 | 2 | EFO_0800294 | |
| Disease | X-24574 measurement | 4.75e-04 | 7 | 142 | 2 | EFO_0800897 | |
| Disease | nephrosis (implicated_via_orthology) | 4.75e-04 | 7 | 142 | 2 | DOID:2527 (implicated_via_orthology) | |
| Disease | microcephaly (implicated_via_orthology) | 4.89e-04 | 32 | 142 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | Acute erythroleukemia - M6a subtype | 6.32e-04 | 8 | 142 | 2 | C2930975 | |
| Disease | Acute myeloid leukemia FAB-M6 | 6.32e-04 | 8 | 142 | 2 | C2930976 | |
| Disease | Acute erythroleukemia - M6b subtype | 6.32e-04 | 8 | 142 | 2 | C2930977 | |
| Disease | Acute erythroleukemia | 6.32e-04 | 8 | 142 | 2 | C2930974 | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 8.10e-04 | 9 | 142 | 2 | EFO_0800278 | |
| Disease | Schizophrenia and related disorders | 8.10e-04 | 9 | 142 | 2 | C0809983 | |
| Disease | Asthma, Occupational | 1.01e-03 | 10 | 142 | 2 | C0264423 | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 1.01e-03 | 10 | 142 | 2 | EFO_0022090 | |
| Disease | disseminated intravascular coagulation (is_marker_for) | 1.01e-03 | 10 | 142 | 2 | DOID:11247 (is_marker_for) | |
| Disease | susceptibility to influenza measurement | 1.01e-03 | 10 | 142 | 2 | EFO_0803537 | |
| Disease | B-lymphoblastic leukemia/lymphoma (is_implicated_in) | 1.01e-03 | 10 | 142 | 2 | DOID:0080630 (is_implicated_in) | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 1.01e-03 | 10 | 142 | 2 | EFO_0800289 | |
| Disease | diffusing capacity of the lung for carbon monoxide | 1.21e-03 | 96 | 142 | 4 | EFO_0009369 | |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 1.23e-03 | 11 | 142 | 2 | EFO_0801531 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 1.23e-03 | 11 | 142 | 2 | EFO_0800295 | |
| Disease | testosterone measurement | DOCK4 CYP3A7 GTF2A1L CYP3A4 NPEPPS DNAH2 WDR81 TTC27 RYK SUGCT MTHFD1 MACF1 CTPS1 TP53 SOAT1 | 1.27e-03 | 1275 | 142 | 15 | EFO_0004908 |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 1.47e-03 | 12 | 142 | 2 | EFO_0800291 | |
| Disease | age of onset of multiple sclerosis | 1.47e-03 | 12 | 142 | 2 | OBA_2001029 | |
| Disease | myocardial infarction | 1.58e-03 | 350 | 142 | 7 | EFO_0000612 | |
| Disease | Thrombosis | 1.71e-03 | 49 | 142 | 3 | C0040053 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 1.73e-03 | 13 | 142 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 1.73e-03 | 13 | 142 | 2 | EFO_0800284 | |
| Disease | cerebral amyloid angiopathy | 1.92e-03 | 51 | 142 | 3 | EFO_0006790 | |
| Disease | estradiol measurement | 2.00e-03 | 110 | 142 | 4 | EFO_0004697 | |
| Disease | congenital hypothyroidism (implicated_via_orthology) | 2.01e-03 | 14 | 142 | 2 | DOID:0050328 (implicated_via_orthology) | |
| Disease | X-21470 measurement | 2.01e-03 | 14 | 142 | 2 | EFO_0800817 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 2.01e-03 | 14 | 142 | 2 | EFO_0800283 | |
| Disease | Hereditary Breast and Ovarian Cancer Syndrome | 2.01e-03 | 14 | 142 | 2 | C0677776 | |
| Disease | Nephrosis | 2.32e-03 | 15 | 142 | 2 | C0027720 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 2.32e-03 | 15 | 142 | 2 | EFO_0800301 | |
| Disease | X-21410 measurement | 2.64e-03 | 16 | 142 | 2 | EFO_0800813 | |
| Disease | Polyposis, Adenomatous Intestinal | 2.64e-03 | 16 | 142 | 2 | C2713442 | |
| Disease | Familial Intestinal Polyposis | 2.64e-03 | 16 | 142 | 2 | C2713443 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 2.64e-03 | 16 | 142 | 2 | EFO_0800305 | |
| Disease | pulse pressure measurement | TDRD15 ATP8B4 MYO1C TEC CCDC77 CEP164 RYK CRK DHX15 CDCA7 SUGCT IK TEC TP53 CDH17 | 2.96e-03 | 1392 | 142 | 15 | EFO_0005763 |
| Disease | pre-malignant neoplasm (biomarker_via_orthology) | 2.98e-03 | 17 | 142 | 2 | DOID:0060071 (biomarker_via_orthology) | |
| Disease | Adenomatous Polyposis Coli | 2.98e-03 | 17 | 142 | 2 | C0032580 | |
| Disease | Charcot-Marie-Tooth disease type 2 | 2.98e-03 | 17 | 142 | 2 | cv:C0270914 | |
| Disease | ischemia (biomarker_via_orthology) | 3.35e-03 | 18 | 142 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | Disorder of organic acid metabolism | 3.35e-03 | 18 | 142 | 2 | cv:C1263739 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 3.35e-03 | 18 | 142 | 2 | EFO_0800288 | |
| Disease | cystathionine measurement | 3.73e-03 | 19 | 142 | 2 | EFO_0010474 | |
| Disease | p-tau:beta-amyloid 1-42 ratio measurement | 3.73e-03 | 19 | 142 | 2 | EFO_0007709 | |
| Disease | etiocholanolone glucuronide measurement | 3.73e-03 | 19 | 142 | 2 | EFO_0800362 | |
| Disease | androsterone glucuronide measurement | 4.13e-03 | 20 | 142 | 2 | EFO_0800317 | |
| Disease | viral load | 4.29e-03 | 136 | 142 | 4 | EFO_0010125 | |
| Disease | dehydroepiandrosterone sulphate measurement | 4.35e-03 | 68 | 142 | 3 | EFO_0007001 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EVLRYDDRAIGELLS | 421 | Q9HAC7 | |
| RQLAIIGDDINRRYD | 76 | Q16611 | |
| NDRVALYIAREGKEE | 111 | Q86V21 | |
| SGVNYLILDDDDRER | 471 | O75815 | |
| QYGDVLVRNLRREAE | 151 | P20815 | |
| LRGEDQEVELVVDYI | 416 | Q3SY69 | |
| YEALERRRILEVEGF | 406 | Q9BR77 | |
| DERIAGLYEEIERDL | 626 | Q8TF62 | |
| RVRENLEVGYEVLTI | 361 | Q9NYQ6 | |
| VDEEDYELGRQKLLR | 296 | O75618 | |
| LERYGVIILDEAHER | 251 | O43143 | |
| QDLRLIRETGDDYRN | 146 | Q96C86 | |
| ARYEIVVEARDAQGL | 221 | P33151 | |
| LIESAEELIRDGRYT | 271 | Q13217 | |
| LEDGRVEYRVALTED | 621 | Q76LX8 | |
| DVRFQGERLVYEISL | 351 | Q16853 | |
| GVILRQEEAEYVRAL | 126 | P46108 | |
| IERGLRVIEITIYED | 116 | Q7Z5G4 | |
| TVLDGNLIIRYDVDR | 231 | Q14624 | |
| AERVLRYLVEVEELA | 6 | Q9NUG6 | |
| SGEEQERVLRYLEDE | 126 | Q96D70 | |
| TARELVAEALERYGL | 171 | Q5U651 | |
| VREPELEDLTRYDVG | 411 | P49792 | |
| FYREVDQREIEQLVG | 151 | Q9Y272 | |
| RGQDIEYIEIRSDAD | 1156 | Q92878 | |
| ELEDLARYDVGAIRA | 416 | Q99666 | |
| ELEDLARYDVGAIRA | 416 | O14715 | |
| IYEDVIRGCLLQRID | 571 | Q86XR2 | |
| ERLIGRYDEEVVKEL | 36 | O60271 | |
| DYREVEKLLRAVADG | 666 | Q96NW4 | |
| DDELEGRRIAFILYL | 156 | Q8N543 | |
| LYEVGRQRLAEDEDE | 1386 | Q9Y4B6 | |
| DRLADINYEGRLEAV | 841 | P52948 | |
| GVVDLDLDELNVYAR | 96 | Q8IYB1 | |
| YSVNEGLVAEIERLR | 636 | Q8NHV4 | |
| EDEGRYRCELINGIE | 121 | Q9GZV7 | |
| RYEAEITALERERGV | 51 | Q9NVR5 | |
| LDIEIATYRRLLEGE | 416 | P78386 | |
| VQGRDDALERRINEY | 706 | Q13201 | |
| ERARLAGEEEALRQY | 236 | Q9BYM8 | |
| IEIATYRRLLEGEEQ | 401 | O43790 | |
| DVLYEEVEELRLVLG | 2206 | Q5SZK8 | |
| QYGDVLVRNLRREAE | 151 | P08684 | |
| ELYRSLGDVLRDVDA | 126 | Q13144 | |
| VRVYGERTELLVDRE | 111 | Q9NVF9 | |
| ETRRLGDVAEVLYQA | 141 | Q9ULL4 | |
| LLIREVREDDIGNYT | 201 | Q9NZN1 | |
| IVKGALDREQRDSYE | 261 | O60245 | |
| QLVEARGRYEELCIV | 506 | P17858 | |
| YRGLRGDDAINEVLE | 256 | P25021 | |
| EQEIATYRRLLEGED | 411 | P08779 | |
| LDVEIATYRRLLEGE | 406 | Q8N1N4 | |
| SYIRDRIEEIRLEGN | 261 | P20774 | |
| RLQELEGTYEENERA | 1751 | P55268 | |
| EELIREIAGLVRRYD | 156 | Q7L5L3 | |
| EIAGLVRRYDRNEIT | 161 | Q7L5L3 | |
| LDEEGQFLVRIIYDD | 31 | Q02153 | |
| RVEGNLRVEYLDDRN | 196 | P04637 | |
| DAEEAVRIAREIGYP | 201 | P05165 | |
| EGALDREIRAEYNIT | 406 | Q9UN67 | |
| EQLELTLGRVEDFYR | 5226 | Q9UPN3 | |
| NTADRIIRVYDGREI | 216 | Q15291 | |
| EFVQGDEEVLRRYLN | 361 | P23677 | |
| ERIELGLLYEEKGER | 1531 | O95248 | |
| EDLTRALGDYARVEQ | 406 | P0CG20 | |
| TLIYRRVLAEDAGEI | 2256 | Q5VST9 | |
| ENLRDGDRYILRQEG | 3486 | Q5VST9 | |
| ELEDLARYDVGAIRA | 416 | A6NKT7 | |
| IDRLQGTTIREEDEY | 96 | P23508 | |
| GLARVIEDNEYTARE | 401 | P08631 | |
| ETYRRILEVEGAEAE | 461 | Q8NA47 | |
| RRVYDITNVLDGIDL | 101 | O75461 | |
| LQLLHGDIEQIRREY | 361 | Q8N1I0 | |
| LLENREDISQYGIAR | 31 | Q9H6J7 | |
| VAYGLLARELERVDS | 121 | Q92947 | |
| ERYVADGERAALVER | 66 | Q7L775 | |
| GEAAYLRVISEEREL | 56 | Q9BQN1 | |
| VALIRYIVLEEEDGA | 476 | Q9H2U1 | |
| LDRYHRIIEIEGNRL | 306 | Q12934 | |
| IGDYLGEREELNLAV | 111 | Q99418 | |
| SGYQDNIARLEEEIR | 361 | P17661 | |
| EARGRLLERNGEDYI | 301 | Q9BTC0 | |
| ELDARDGLRLYEQER | 206 | Q02410 | |
| YEIQIRVLREFGLAD | 686 | Q9P203 | |
| EDIRENEARQLGVGY | 236 | Q6PII3 | |
| EDLVLELIFGYRGRD | 1361 | Q05BV3 | |
| RIDFELREGLVESRY | 846 | Q8NEL9 | |
| QYGDVLVRNLRREAE | 151 | P24462 | |
| LLYVRRIEGEVNEIL | 636 | Q8N6R0 | |
| EEREYVVLIRINDGG | 736 | Q12864 | |
| EEGRKRIDSYLREIE | 2331 | Q9P225 | |
| QLIEDIVRDGRLYAS | 916 | Q8IWY4 | |
| QELIEDIVRDGRLYA | 926 | Q9NQ36 | |
| EQLVEDIVRDGRLYA | 921 | Q8IX30 | |
| LYLSEDEVRRLIGLD | 66 | P34925 | |
| LYSEVAEERERLGQQ | 796 | Q9UPN4 | |
| EAEYFELPELVRRLG | 116 | Q96CX2 | |
| IYVEAEQVEDDRLLR | 506 | P55786 | |
| REIGLLSEEVELYGE | 336 | P11586 | |
| LTALYERLEEERGIL | 451 | Q13474 | |
| VIDGVNYLIDCERRL | 386 | P12532 | |
| IEIATYRRLLEGEEQ | 406 | P78385 | |
| EQGLIDLAIDTYRRA | 271 | O15294 | |
| ELEDLARYDVGAIRA | 416 | Q7Z3J3 | |
| TLVVDYIDEGRLVLE | 156 | P35610 | |
| EEAEGIEYLRVILRS | 186 | Q684P5 | |
| GEYLRLSREIQEAAA | 41 | O60522 | |
| IEVGRENREDYRQIA | 286 | P31948 | |
| NELYTVLLIDRGEEL | 86 | B5MCY1 | |
| HDLRLERGQEYLILE | 196 | P42680 | |
| QRDRLGEQLVEEYLS | 41 | Q8IYG6 | |
| LEEQYLGLALDVDRI | 1226 | Q6P3W6 | |
| LEEQYLGLALDVDRI | 2446 | Q6P3W6 | |
| LEEQYLGLALDVDRI | 711 | A0A087WUL8 | |
| LEEQYLGLALDVDRI | 1931 | A0A087WUL8 | |
| LEEQYLGLALDVDRI | 3151 | A0A087WUL8 | |
| RESYEELLQLEDRLG | 236 | Q6ZSG1 | |
| STRDYEIQRERIELG | 411 | Q05397 | |
| LLEEQGVVDYFLRRL | 256 | P17812 | |
| ERLLDELTLEGVARY | 56 | Q8IXJ6 | |
| EEEAGLLRRQRQYFE | 626 | Q9UL54 | |
| ERAQLEDGRFVYRLL | 361 | Q15562 | |
| AAEGRYEVLRELLEA | 121 | A6NJG2 | |
| LKEEVGSRIADRVYD | 71 | Q5TEU4 | |
| PEELGARILIQERYE | 301 | Q15459 | |
| LVNNLAEIYGRIERE | 331 | Q9NZN3 | |
| EEVDLYRQLSLAGRV | 296 | Q8NEG4 | |
| EIITSEEAERRGQIY | 276 | O43463 | |
| LRNRYGEEVRDALLD | 301 | Q9BWT1 | |
| LRIGDQLVLEEDYDE | 6 | Q9UPV0 | |
| SIREVLYRGNADEEL | 81 | Q96A61 | |
| EDYLRHEIGELQQRL | 736 | P82094 | |
| LEGELEELRQDRTLY | 431 | Q6ZTK2 | |
| DIYAIEELRARGLEV | 466 | P49588 | |
| YRSVIEDVIEGVRNL | 11 | Q9UNN4 | |
| REAPEELLAYEGVRA | 741 | Q12788 | |
| ALERELLEDYRFGRQ | 76 | A6XGL0 | |
| DVQYRLDEDGFLRQR | 2186 | Q9P273 | |
| ERRRQEAEELEGYCI | 176 | Q9UJT2 | |
| RRDGVNKDYEETELI | 106 | Q13123 | |
| EVLELERTLGGYLVE | 726 | Q8IZJ1 | |
| RLELELLRQGEEQYE | 986 | Q00722 | |
| DAEVYRLIEVTGLAR | 466 | Q9Y6X8 | |
| GEEVVVLLEYLERQL | 121 | Q969J2 | |
| TERELLESYIDGRIV | 351 | P00734 | |
| YVAQLILDVRREGDV | 281 | Q6P3X3 | |
| RLELGEELYRLQFID | 281 | Q6ZQQ6 | |
| LYQARRVEDEAQGRE | 886 | Q562E7 | |
| REVYRILQEEGIDLP | 146 | Q6PFW1 | |
| AYETREDIIRLVGEL | 376 | Q9NQA5 | |
| IEIATYRRLLEGEEQ | 401 | Q14533 | |
| RERGALDRIVEYLVG | 251 | Q9C0E8 | |
| GRIREALEVYRQLSE | 81 | Q496Y0 | |
| YQLLEGGEEETLRRL | 241 | O00159 | |
| GLEETLRNLQARYEE | 166 | P07196 | |
| LGDAYDQEIRELRAT | 146 | P07197 |